Ontology list
Cellular componentcytoplasm - GO:0005737; extracellular region part - GO:0044421; plasma membrane part - GO:0044459; extracellular membrane-bounded organelle - GO:0065010; cytoplasmic part - GO:0044444; nucleoplasm - GO:0005654; extracellular organelle - GO:0043230; membrane region - GO:0098589; membrane-bounded organelle - GO:0043227; cell part - GO:0044464; vesicle - GO:0031982; extracellular exosome - GO:0070062; extracellular vesicle - GO:1903561; plasma membrane region - GO:0098590; cytosol - GO:0005829; cellular_component - GO:0005575; organelle - GO:0043226; intracellular part - GO:0044424; membrane part - GO:0044425; basolateral plasma membrane - GO:0016323; membrane - GO:0016020; extracellular vesicular exosome - GO:0070062; membrane-bounded vesicle - GO:0031988;
Molecular functionheterocyclic compound binding - GO:1901363; NAD+ binding - GO:0070403; signal transducer activity - GO:0004871; protein binding - GO:0005515; 15-hydroxyprostaglandin dehydrogenase (nad+) activity - GO:0016404; anion binding - GO:0043168; molecular transducer activity - GO:0060089; protein dimerization activity - GO:0046983; g-protein coupled receptor activity - GO:0004930; prostaglandin receptor activity - GO:0004955; receptor activity - GO:0004872; binding - GO:0005488; prostaglandin e receptor activity - GO:0004957; coenzyme binding - GO:0050662; oxidoreductase activity - GO:0016491; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity - GO:0016404; nad binding - GO:0051287; nucleotide binding - GO:0000166; small molecule binding - GO:0036094; prostanoid receptor activity - GO:0004954; protein homodimerization activity - GO:0042803; oxidoreductase activity; acting on the ch-oh group of donors; nad or nadp as acceptor - GO:0016616; signaling receptor activity - GO:0038023; organic cyclic compound binding - GO:0097159; transmembrane signaling receptor activity - GO:0004888; ion binding - GO:0043167; catalytic activity - GO:0003824; nucleoside phosphate binding - GO:1901265; nad+ binding - GO:0070403; cofactor binding - GO:0048037; NAD binding - GO:0051287; molecular_function - GO:0003674; prostaglandin E receptor activity - GO:0004957; identical protein binding - GO:0042802; oxidoreductase activity; acting on ch-oh group of donors - GO:0016614; icosanoid receptor activity - GO:0004953;
Biological processsingle-organism developmental process - GO:0044767; negative regulation of cellular process - GO:0048523; negative regulation of biological process - GO:0048519; kidney development - GO:0001822; cellular process - GO:0009987; regulation of cellular process - GO:0050794; cyclooxygenase pathway - GO:0019371; multicellular organismal process - GO:0032501; biological_process - GO:0008150; thrombin-activated receptor signaling pathway - GO:0070493; response to lipopolysaccharide - GO:0032496; cellular metabolic process - GO:0044237; oxoacid metabolic process - GO:0043436; positive regulation of apoptotic process - GO:0043065; negative regulation of cell cycle - GO:0045786; arachidonic acid metabolic process - GO:0019369; blood vessel morphogenesis - GO:0048514; fatty acid derivative metabolic process - GO:1901568; enzyme linked receptor protein signaling pathway - GO:0007167; carboxylic acid metabolic process - GO:0019752; prostanoid metabolic process - GO:0006692; single-organism metabolic process - GO:0044710; reproductive process - GO:0022414; organic acid metabolic process - GO:0006082; metabolic process - GO:0008152; small molecule metabolic process - GO:0044281; multi-multicellular organism process - GO:0044706; ovulation - GO:0030728; organic substance metabolic process - GO:0071704; g-protein coupled receptor signaling pathway - GO:0007186; cell surface receptor signaling pathway - GO:0007166; lipid metabolic process - GO:0006629; transmembrane receptor protein serine/threonine kinase signaling pathway - GO:0007178; long-chain fatty acid metabolic process - GO:0001676; regulation of cell cycle - GO:0051726; positive regulation of vascular smooth muscle cell proliferation - GO:1904707; prostaglandin metabolic process - GO:0006693; monocarboxylic acid metabolic process - GO:0032787; ductus arteriosus closure - GO:0097070; lipoxin biosynthetic process - GO:2001301; oxidation-reduction process - GO:0055114; thrombin receptor signaling pathway - GO:0070493; parturition - GO:0007567; response to ethanol - GO:0045471; single organism reproductive process - GO:0044702; artery morphogenesis - GO:0048844; transforming growth factor beta receptor signaling pathway - GO:0007179; cellular lipid metabolic process - GO:0044255; regulation of biological process - GO:0050789; signal transduction - GO:0007165; unsaturated fatty acid metabolic process - GO:0033559; icosanoid metabolic process - GO:0006690; single-organism cellular process - GO:0044763; multi-organism process - GO:0051704; lipoxygenase pathway - GO:0019372; developmental process - GO:0032502; response to estradiol - GO:0032355; female pregnancy - GO:0007565; anatomical structure morphogenesis - GO:0009653; single-organism process - GO:0044699; long-chain fatty acid biosynthetic process - GO:0042759; biological regulation - GO:0065007; multi-organism reproductive process - GO:0044703; lipoxin metabolic process - GO:2001300; multicellular organismal reproductive process - GO:0048609; fatty acid metabolic process - GO:0006631; primary metabolic process - GO:0044238;